These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 34222010)

  • 1. Real Life Data on Patient-Reported Outcomes and Neuro-Cognitive Functioning of Lung Cancer Patients: The PRO-Long Study.
    Van Der Weijst L; Surmont V; Schrauwen W; Lievens Y
    Front Oncol; 2021; 11():685605. PubMed ID: 34222010
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study).
    Van der Weijst L; Aguado-Barrera ME; Azria D; Berkovic P; Boisselier P; Briers E; Bultijnck R; Calvo-Crespo P; Chang-Claude J; Choudhury A; Defraene G; Demontois S; Dunning AM; Elliott RM; Ennis D; Faivre-Finn C; Franceschini M; Gutiérrez-Enríquez S; Herskind C; Higginson DS; Kerns SL; Johnson K; Mollà M; Lambrecht M; Ramos M; Rancati T; Rimner A; Rosenstein BS; De Ruysscher D; Salem A; Sangalli C; Seibold P; Sosa-Fajardo P; Sperk E; Stobart H; Summersgill H; Surmont V; Symonds P; Taboada-Lorenzo B; Talbot CJ; Valdagni R; Vega A; Veldeman L; Veldwijk MR; Ward T; Webb A; West CML; ; Lievens Y
    Lung Cancer; 2022 Apr; 166():228-241. PubMed ID: 35334417
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurocognitive functioning following lung cancer treatment: The PRO-Long Study.
    van der Weijst L; Lievens Y; Surmont V; Schrauwen W
    Tech Innov Patient Support Radiat Oncol; 2022 Mar; 21():36-40. PubMed ID: 35243042
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.
    van der Weijst L; Azria D; Berkovic P; Boisselier P; Briers E; Bultijnck R; Chang-Claude J; Choudhury A; Defraene G; Demontois S; Elliott RM; Ennis D; Faivre-Finn C; Franceschini M; Giandini T; Giraldo A; Gutiérrez-Enríquez S; Herskind C; Higginson DS; Kerns SL; Johnson K; Lambrecht M; Lang P; Ramos M; Rancati T; Rimner A; Rosenstein BS; De Ruysscher D; Salem A; Sangalli C; Seibold P; Sosa Fajardo P; Sperk E; Stobart H; Summersgill H; Surmont V; Symonds P; Taboada-Valladares B; Talbot CJ; Vega A; Veldeman L; Veldwijk MR; Ward T; Webb A; West CML; Lievens Y;
    Radiother Oncol; 2022 Nov; 176():127-137. PubMed ID: 36195214
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Quality of Life Is Independently Associated With Neurocognitive Function in Patients With Brain Tumors: Analysis of a Prospective Clinical Trial.
    Salans M; Tibbs MD; Huynh-Le MP; Yip A; Tringale K; Karunamuni R; Xu R; Reyes A; Macari AC; Pan-Weisz T; McDonald CR; Hattangadi-Gluth JA
    Int J Radiat Oncol Biol Phys; 2021 Nov; 111(3):754-763. PubMed ID: 34102297
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Patient-reported outcomes and functional exercise capacity in a real-life setting in non-small cell lung cancer patients undergoing stereotactic body radiotherapy: the Lung PLUS study.
    van der Weijst L; Bultijnck R; Van Damme A; Huybrechts V; van Eijkeren M; Lievens Y
    Front Oncol; 2023; 13():1220248. PubMed ID: 37692843
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Health-related quality of life in patients with microsatellite instability-high or mismatch repair deficient metastatic colorectal cancer treated with first-line pembrolizumab versus chemotherapy (KEYNOTE-177): an open-label, randomised, phase 3 trial.
    Andre T; Amonkar M; Norquist JM; Shiu KK; Kim TW; Jensen BV; Jensen LH; Punt CJA; Smith D; Garcia-Carbonero R; Sevilla I; De La Fouchardiere C; Rivera F; Elez E; Diaz LA; Yoshino T; Van Cutsem E; Yang P; Farooqui M; Le DT
    Lancet Oncol; 2021 May; 22(5):665-677. PubMed ID: 33812497
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Health-related quality of life and neurocognitive functioning in patients with recurrent glioblastoma treated with intracerebral immune checkpoint inhibition.
    Geens W; Vanlaer N; Nijland L; Van Laere S; Schwarze JK; Bruneau M; Neyns B; Rogiers A; Duerinck J
    J Neurooncol; 2024 May; 168(1):159-169. PubMed ID: 38502281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Individual changes in neurocognitive functioning and health-related quality of life in patients with brain oligometastases treated with stereotactic radiotherapy.
    van der Meer PB; Habets EJJ; Wiggenraad RG; Verbeek-de Kanter A; Lycklama À Nijeholt GJ; Zwinkels H; Klein M; Dirven L; Taphoorn MJB
    J Neurooncol; 2018 Sep; 139(2):359-368. PubMed ID: 29663172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Health-related quality of life in patients with locally recurrent or metastatic breast cancer treated with etirinotecan pegol versus treatment of physician's choice: Results from the randomised phase III BEACON trial.
    Twelves C; Cortés J; O'Shaughnessy J; Awada A; Perez EA; Im SA; Gómez-Pardo P; Schwartzberg LS; Diéras V; Yardley DA; Potter DA; Mailliez A; Moreno-Aspitia A; Ahn JS; Zhao C; Hoch U; Tagliaferri M; Hannah AL; Rugo HS
    Eur J Cancer; 2017 May; 76():205-215. PubMed ID: 28360015
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neurocognitive Function, Psychosocial Outcome, and Health-Related Quality of Life of the First-Generation Metastatic Melanoma Survivors Treated with Ipilimumab.
    Rogiers A; Leys C; Lauwyck J; Schembri A; Awada G; Schwarze JK; De Cremer J; Theuns P; Maruff P; De Ridder M; Bernheim JL; Neyns B
    J Immunol Res; 2020; 2020():2192480. PubMed ID: 32775464
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Neurocognitive functioning and health-related quality of life in patients treated with stereotactic radiotherapy for brain metastases: a prospective study.
    Habets EJ; Dirven L; Wiggenraad RG; Verbeek-de Kanter A; Lycklama À Nijeholt GJ; Zwinkels H; Klein M; Taphoorn MJ
    Neuro Oncol; 2016 Mar; 18(3):435-44. PubMed ID: 26385615
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nivolumab versus standard, single-agent therapy of investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck (CheckMate 141): health-related quality-of-life results from a randomised, phase 3 trial.
    Harrington KJ; Ferris RL; Blumenschein G; Colevas AD; Fayette J; Licitra L; Kasper S; Even C; Vokes EE; Worden F; Saba NF; Kiyota N; Haddad R; Tahara M; Grünwald V; Shaw JW; Monga M; Lynch M; Taylor F; DeRosa M; Morrissey L; Cocks K; Gillison ML; Guigay J
    Lancet Oncol; 2017 Aug; 18(8):1104-1115. PubMed ID: 28651929
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Objective neurocognitive functioning and neurocognitive complaints in patients with high-grade glioma: Evidence of cognitive awareness from the European Organisation for Research and Treatment of Cancer brain tumour clinical trials.
    Caramanna I; Bottomley A; Drijver AJ; Twisk J; van den Bent M; Idbaih A; Wick W; Pe M; Klein M; Reijneveld JC;
    Eur J Cancer; 2021 Feb; 144():162-168. PubMed ID: 33348088
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lenvatinib versus sorafenib for first-line treatment of unresectable hepatocellular carcinoma: patient-reported outcomes from a randomised, open-label, non-inferiority, phase 3 trial.
    Vogel A; Qin S; Kudo M; Su Y; Hudgens S; Yamashita T; Yoon JH; Fartoux L; Simon K; López C; Sung M; Mody K; Ohtsuka T; Tamai T; Bennett L; Meier G; Breder V
    Lancet Gastroenterol Hepatol; 2021 Aug; 6(8):649-658. PubMed ID: 34087115
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical decision-making and health-related quality of life during first-line and maintenance therapy in patients with advanced non-small cell lung cancer (NSCLC): findings from a real-world setting.
    Sztankay M; Giesinger JM; Zabernigg A; Krempler E; Pall G; Hilbe W; Burghuber O; Hochmair M; Rumpold G; Doering S; Holzner B
    BMC Cancer; 2017 Aug; 17(1):565. PubMed ID: 28835219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Longitudinal changes of health-related quality of life over 10 years in breast cancer patients treated with radiotherapy following breast-conserving surgery.
    Gao Y; Rosas JC; Fink H; Behrens S; Chang-Claude J; Seibold P
    Qual Life Res; 2023 Sep; 32(9):2639-2652. PubMed ID: 37093543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does palliative chemotherapy really palliate and are we measuring it correctly? A mixed methods longitudinal study of health related quality of life in advanced soft tissue sarcoma.
    Gough N; Koffman J; Ross JR; Riley J; Judson I
    PLoS One; 2019; 14(9):e0210731. PubMed ID: 31557183
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurocognitive functioning and health-related quality of life in adult medulloblastoma patients: long-term outcomes of the NOA-07 study.
    Dirven L; Luerding R; Beier D; Bumes E; Reinert C; Seidel C; Bonsanto MM; Bremer M; Rieken S; Combs SE; Herrlinger U; Seliger C; Kuntze H; Mayer-Steinacker R; Dieing A; Bartels C; Schnell O; Weyerbrock A; Seidel S; Grauer O; Nadji-Ohl M; Paulsen F; Weller M; Wick W; Hau P
    J Neurooncol; 2020 May; 148(1):117-130. PubMed ID: 32367436
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Health-Related Quality of Life during Chemoradiation in Locally Advanced Rectal Cancer: Impacts and Ethnic Disparities.
    Lim SH; Ip E; Ng W; Chua W; Asghari R; Roohullah A; Descallar J; Henderson C; Spring K; de Souza P; King MT
    Cancers (Basel); 2019 Aug; 11(9):. PubMed ID: 31466306
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.